Evidence map›Paper›PMID 35473600›Full record

ArticleBMC pharmacology & toxicology2022

Interaction between AhR and HIF-1 signaling pathways mediated by ARNT/HIF-1β.

Mengdi Zhang, Yuxia Hu, Fan Yang, Jingwen Zhang, Jianxin Zhang, Wanjia Yu, Minjie Wang, Xiaoli Lv, Jun Li, Tuya Bai and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC pharmacology & toxicology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Developmental age and clinical illness driveFrontiers in pharmacology · 2026
    Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Classification and regulatory interactions of key transcription factors in COVID-19.Frontiers in cellular and infection microbiology · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Mengdi Zhang *Department of Pharmacy Experimental Teaching Center of Pharmaceutical College, Inner Mongolia Medical University, Hohhot, China.
Yuxia Hu *Inner Mongolia Research Center for Drug Screening, Hohhot, China.
Fan Yang *School of Pharmaceutical Science, Shanxi Medical University, Hohhot, China.
Jingwen ZhangDepartment of Pharmacology of Pharmaceutical College, Inner Mongolia Medical University, Hohhot, China.
Jianxin ZhangDepartment of Pharmacology of Pharmaceutical College, Inner Mongolia Medical University, Hohhot, China.
Wanjia YuDepartment of Pharmacology of Pharmaceutical College, Inner Mongolia Medical University, Hohhot, China.
Minjie WangDepartment of Pharmacology of Basic medical College, Inner Mongolia Medical university, Hohhot, China.
Xiaoli LvInner Mongolia Research Center for Drug Screening, Hohhot, China.
Jun LiInner Mongolia Research Center for Drug Screening, Hohhot, China.
Tuya BaiInner Mongolia Research Center for Drug Screening, Hohhot, China. baituya12345@163.com.
Fuhou ChangInner Mongolia Research Center for Drug Screening, Hohhot, China. nmgchangfh@163.com.
Inner Mongolia Medical University · CNShanxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe main causes of lung cancer are smoking, environmental pollution and genetic susceptibility. It is an indisputable fact that PAHs are related to lung cancer, and benzo(a) pyrene is a representative of PAHs. The purpose of the current investigation was to investigate the interaction between AhR and HIF-1 signaling pathways in A549 cells, which provide some experimental basis for scientists to find drugs that block AhR and HIF-1 signaling pathway to prevent and treat cancer.

methodsThis project adopts the CYP1A1 signaling pathways and the expression of CYP1B1 is expressed as a measure of AhR strength index. The expression of VEGF and CAIX volume as a measure of the strength of the signal path HIF-1 indicators. Through the construction of plasmid vector, fluorescence resonance energy transfer, real-time quantitative PCR, western blotting and immunoprecipitation, the interaction between AhR signaling pathway and HIF-1 signaling pathway was observed.

resultsBaP can enhance the binding ability of HIF-1α protein to HIF-1β/ARNT in a dose-dependent manner without CoCl

conclusionIt is shown that activation of the AhR signaling pathway does not inhibit the HIF-1α signaling pathway, but activation of the HIF-1α signaling pathway inhibits the AhR signaling pathway.

Indexed as

Aryl Hydrocarbon Receptor Nuclear TranslocatorLung NeoplasmsReceptors, Aryl HydrocarbonA549 CellsHumansSignal TransductionARNT protein, humanAryl Hydrocarbon Receptor Nuclear TranslocatorReceptors, Aryl HydrocarbonAryl hydrocarbon receptorAryl hydrocarbon receptor nuclear translocatorBenzopyreneCoCl2Hypoxia-inducible factor-1α

Identifiers

PMID35473600
PMCPMC9044668
OpenAlexW4224999651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.